Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ROIVANT SCIENCES LTD. (ROIV) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ROIVANT SCIENCES LTD. (ROIV), most recent 12 months reported: revenue $7.53M, net loss $266.25M, free cash flow -$821.06M. Latest balance sheet on file: liquid cash $3.84B. From SEC filings. More on ROIVANT SCIENCES LTD.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: INTERNATIONAL STEM CELL CORPORATION · Aclaris Therapeutics, Inc. · Coya Therapeutics, Inc. · Adagene Inc. · Alumis Inc. · NewAmsterdam Pharma Company N.V. · HCW Biologics Inc. · RANI THERAPEUTICS HOLDINGS, INC.

Stock screener

Watchlist